GUTTMACHER INSTITUTE lobbying for GUTTMACHER INSTITUTE

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 4

SAMIRA DAMAVANDI

Previously held: Senior Federal Policy Associate
ANNA BERNSTEIN

Previously held: Principal Federal Policy Advisor
ANN NOLI VEGA

Previously held: Senior Digital Communications Manager
AMY FRIEDRICH-KARNIK

Previously held: Director of Federal Policy

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Budget/Appropriations

FY 27 Appropriations- Signed on to letter to House and Senate appropriators opposing anti-abortion riders in Defense and MilConVA Approps Bills

Family issues/Abortion/Adoption

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- met with House offices to cosponsor the bill -Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone - Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone - Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims - Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton - Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone - HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill - S 5108, HR 9941- Right to IVF Act, endorsed bill - HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship. - HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship

Foreign Relations

-HR 10600, S 5565-Abortion is Healthcare Everywhere Act- Met with Rep. Schakowsky and Sen. Booker staff on bill reintroduction, reviewed text, emails to House and Senate for cosponsors, social media content development and engagement in support of bill re-introduction.

Health Issues

- HR 4104- Health Equity and Access under the Law for Immigrant Families Act of 2025- emails to House for cosponsorship - HR 10597, S 5539- Affordability is Access Act, emails to House and Senate for cosponsorship, social media content development and engagement in support of bill re-introduction. -Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton

Bills named in this filing 6

H.R. 4611
EACH Act of 2025
H.R. 7983
Clean Water for All Life Act
H.R. 10597
Affordability is Access Act of 2026
H.R. 9941
Right to IVF Act of 2026
H.R. 10600
Abortion is Health Care Everywhere Act of 2026
H.R. 4104
Health Equity and Access under the Law for Immigrant Families Act of 2025